Clinical Trial Update: Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating single ascending doses of the AAB-001 vaccine in Japanese patients with Alzheimer's disease; the trial is completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AAB-001 vaccine (AAB-001)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2014-09-04